SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma. (2019)

First Author: Carreno G
Attributed to:  Molecular and Cellular Mechanisms Underlying Pituitary Tumours funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1530/erc-18-0538

PubMed Identifier: 30645190

Publication URI: http://europepmc.org/abstract/MED/30645190

Type: Journal Article/Review

Volume: 26

Parent Publication: Endocrine-related cancer

Issue: 3

ISSN: 1351-0088